Works by Dispenzieri, Angela
Results: 374
Multiple Myeloma in the Very Old: An lASIA Conference Report.
- Published in:
- 2014
- By:
- Publication type:
- Conference Paper/Materials
Development of a conceptual model of patient-reported outcomes in light chain amyloidosis: a qualitative study.
- Published in:
- Quality of Life Research, 2022, v. 31, n. 4, p. 1083, doi. 10.1007/s11136-021-02943-w
- By:
- Publication type:
- Article
Real-life sensitivity of flow cytometry minimal residual disease assessment for plasma cell neoplasms.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Clinical features associated with poor response and early relapse following BCMA-directed therapies in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01081-z
- By:
- Publication type:
- Article
Outcomes of patients with multiple myeloma refractory to standard dose vs low dose lenalidomide.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01039-1
- By:
- Publication type:
- Article
Mode of progression in smoldering multiple myeloma: a study of 406 patients.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-00980-5
- By:
- Publication type:
- Article
Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00957-w
- By:
- Publication type:
- Article
Muscle and fat composition in patients with newly diagnosed multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00934-3
- By:
- Publication type:
- Article
Long-term outcomes of allogeneic stem cell transplant in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00900-z
- By:
- Publication type:
- Article
Conditional survival in multiple myeloma and impact of prognostic factors over time.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00852-4
- By:
- Publication type:
- Article
Utility of flow cytometry screening before MRD testing in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00832-8
- By:
- Publication type:
- Article
Conditional survival in multiple myeloma and impact of prognostic factors over time.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00852-4
- By:
- Publication type:
- Article
Utility of flow cytometry screening before MRD testing in multiple myeloma.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Artificial intelligence-enabled screening strategy for drug repurposing in monoclonal gammopathy of undetermined significance.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00798-7
- By:
- Publication type:
- Article
Defining drug/drug class refractoriness vs lines of therapy in relapsed/refractory multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00785-y
- By:
- Publication type:
- Article
Second- and third-line treatment strategies in multiple myeloma: a referral-center experience.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 12, p. 1, doi. 10.1038/s41408-022-00757-8
- By:
- Publication type:
- Article
Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathy.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00752-z
- By:
- Publication type:
- Article
Comparison of two free light chain assays: performance of the involved free light chain ratio and implications for diagnosis of multiple myeloma.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00722-5
- By:
- Publication type:
- Article
Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 6, p. 1, doi. 10.1038/s41408-022-00680-y
- By:
- Publication type:
- Article
Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County, Minnesota.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 4, p. 1, doi. 10.1038/s41408-022-00659-9
- By:
- Publication type:
- Article
Treatment and outcomes of patients with light chain amyloidosis who received a second line of therapy post autologous stem cell transplantation.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 4, p. 1, doi. 10.1038/s41408-022-00655-z
- By:
- Publication type:
- Article
Mass-Fix better predicts for PFS and OS than standard methods among multiple myeloma patients participating on the STAMINA trial (BMT CTN 0702 /07LT).
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 2, p. 1, doi. 10.1038/s41408-022-00624-6
- By:
- Publication type:
- Article
A simple additive staging system for newly diagnosed multiple myeloma.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-022-00611-x
- By:
- Publication type:
- Article
Assessing the prognostic utility of smoldering multiple myeloma risk stratification scores applied serially post diagnosis.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 11, p. 1, doi. 10.1038/s41408-021-00569-2
- By:
- Publication type:
- Article
The Effect of Duration of Lenalidomide Maintenance and Outcomes of Different Salvage Regimens in Patients with Multiple Myeloma (MM).
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 9, p. 1, doi. 10.1038/s41408-021-00548-7
- By:
- Publication type:
- Article
Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 2, p. 1, doi. 10.1038/s41408-021-00408-4
- By:
- Publication type:
- Article
Correlation between urine ACR and 24-h proteinuria in a real-world cohort of systemic AL amyloidosis patients.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 12, p. 1, doi. 10.1038/s41408-020-00391-2
- By:
- Publication type:
- Article
Characteristics of exceptional responders to autologous stem cell transplantation in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 8, p. N.PAG, doi. 10.1038/s41408-020-00353-8
- By:
- Publication type:
- Article
Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 8, p. N.PAG, doi. 10.1038/s41408-020-00348-5
- By:
- Publication type:
- Article
Venetoclax for the treatment of translocation (11;14) AL amyloidosis.
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous stem cell transplant (ASCT)
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 5, p. 1, doi. 10.1038/s41408-020-0311-8
- By:
- Publication type:
- Article
A validated composite organ and hematologic response model for early assessment of treatment outcomes in light chain amyloidosis.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 4, p. 1, doi. 10.1038/s41408-020-0306-5
- By:
- Publication type:
- Article
The CCND1 c.870G risk allele is enriched in individuals of African ancestry with plasma cell dyscrasias.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Blood mass spectrometry detects residual disease better than standard techniques in light-chain amyloidosis.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 2, p. 1, doi. 10.1038/s41408-020-0291-8
- By:
- Publication type:
- Article
Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 12, p. 1, doi. 10.1038/s41408-019-0263-z
- By:
- Publication type:
- Article
Mass cytometry dissects T cell heterogeneity in the immune tumor microenvironment of common dysproteinemias at diagnosis and after first line therapies.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 9, p. N.PAG, doi. 10.1038/s41408-019-0234-4
- By:
- Publication type:
- Article
Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 6, p. N.PAG, doi. 10.1038/s41408-019-0210-z
- By:
- Publication type:
- Article
Hypovitaminosis D Is Prevalent in Patients With Renal AL Amyloidosis and Associated With Renal Outcome.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.891712
- By:
- Publication type:
- Article
Association of Thrombocytopenia With Disease Burden, High-Risk Cytogenetics, and Survival in Newly Diagnosed Multiple Myeloma Patients Treated With Novel Therapies.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 10, p. e329, doi. 10.1016/j.clml.2024.05.020
- By:
- Publication type:
- Article
Predictors and Impact of Timing of Disease Progression Following Primary Therapy in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 3, p. e104, doi. 10.1016/j.clml.2023.11.008
- By:
- Publication type:
- Article
P-140: Monoclonal proteinuria ≥200 mg/24h predicts progression risk in asymptomatic multiple myeloma with a free light chain ratio ≥100.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S111, doi. 10.1016/S2152-2650(21)02267-9
- By:
- Publication type:
- Article
OAB-038: Graded cardiac response criteria for AL amyloidosis: the impact of depth of cardiac response on survival.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S24, doi. 10.1016/S2152-2650(21)02112-1
- By:
- Publication type:
- Article
OAB-037: Assessing the prognostic utility of the Mayo 2018 and IMWG 2020 smoldering multiple myeloma risk stratification scores applied post diagnosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S24, doi. 10.1016/S2152-2650(21)02111-X
- By:
- Publication type:
- Article
OAB-036: Graded renal response criteria and revised renal progression criteria for light chain (AL) amyloidosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S23, doi. 10.1016/S2152-2650(21)02110-8
- By:
- Publication type:
- Article
OAB-034: Evaluating the impact of cytogenetic abnormalities on treatment outcomes in patients with AL amyloidosis: subanalyses from the ANDROMEDA study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S22, doi. 10.1016/S2152-2650(21)02108-X
- By:
- Publication type:
- Article
MM-315: Impact of Stratification of Levels of Serum Lactate Dehydrogenase (LDH) at Diagnosis on Overall Survival (OS) in Newly Diagnosed Multiple Myeloma (NDMM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S435, doi. 10.1016/S2152-2650(21)01970-4
- By:
- Publication type:
- Article
MM-431: A Comparison Between Daratumumab and Non-Daratumumab-Based Salvage Regimens Used at First Relapse Post-Lenalidomide Maintenance in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S444, doi. 10.1016/S2152-2650(21)01987-X
- By:
- Publication type:
- Article
MM-429: Impact of Prolonged Lenalidomide Maintenance (≥3 years) and Outcomes in Patients with Multiple Myeloma Post-Autologous Stem Cell Transplant.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S443, doi. 10.1016/S2152-2650(21)01986-8
- By:
- Publication type:
- Article
TCL-461: Clinical Activity of Systemic VSV-IFNβ-NIS Oncolytic Virotherapy in Patients with Relapsed Refractory Hematologic Malignancies.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S416, doi. 10.1016/S2152-2650(21)01935-2
- By:
- Publication type:
- Article
IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S401, doi. 10.1016/S2152-2650(21)01906-6
- By:
- Publication type:
- Article